Daito Pharmaceutical Co (TSE:4577) Total Long-Term Assets: 円36,654 Mil (As of Feb. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TSE:4577 Daito Pharmaceutical Co Ltd TSE:4577
83 GF Score
Price 円1,276.00
GF Value 円1,280.49
Valuation Fairly Valued
! 3 Warning Signs
View Full Analysis

What is Daito Pharmaceutical Co Total Long-Term Assets?

Daito Pharmaceutical Co TSE:4577 +2.74% 83 Total Long-Term Assets is 円36,654 Mil as of Feb. 2026. GuruFocus rates TSE:4577 with a GF Score™ of 83/100 and a GF Value™ of 円1,280.49 (Fairly Valued). The stock has 3 warning signs investors should review.

Total Long-Term Assets includes Investments And Advances, Intangible Assets, Property, Plant and Equipment and Other Long Term Assets. Daito Pharmaceutical Co's Total Long-Term Assets for the quarter that ended in Feb. 2026 was 円36,654 Mil.

Daito Pharmaceutical Co Total Long-Term Assets Related Terms

Daito Pharmaceutical Co Total Long-Term Assets Historical Data

* Premium members only.

The historical data trend for Daito Pharmaceutical Co's Total Long-Term Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Daito Pharmaceutical Co Total Long-Term Assets Chart

Daito Pharmaceutical Co Annual Data
Trend May17 May18 May19 May20 May21 May22 May23 May24 May25 May26
Total Long-Term Assets
Get a 7-Day Free Trial Premium Member Only Premium Member Only 27,030.00 29,889.00 36,248.00 36,296.00 36,662.00

Daito Pharmaceutical Co Quarterly Data
Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24 May24 Aug24 Nov24 Feb25 May25 Aug25 Nov25 Feb26 May26
Total Long-Term Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 36,296.00 37,468.00 37,231.00 36,654.00 36,662.00
TSE:4577
83GF Score
Daito Pharmaceutical Co Ltd TSE:4577
Total Long-Term Assets is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Daito Pharmaceutical Co Total Long-Term Assets Calculation

Total Long-Term Assets are the sum of the carrying amounts of all assets that are expected to be realized in cash, sold or consumed longer than one year. It includes Investments And Advances, Intangible Assets, Property, Plant and Equipment and Other Long Term Assets.

Frequently Asked Questions Learn more about Total Long-Term Assets →
What does a Total Long-Term Assets of 円36,654 Mil mean?
Daito Pharmaceutical Co (TSE:4577) has a Total Long-Term Assets of 円36,654 Mil as of Feb. 2026. Total Long-Term Assets are assets that are expected to be realized in cash, sold or consumed longer than one year. View historical data on Daito Pharmaceutical Co and its competitors.
Is Daito Pharmaceutical Co's Total Long-Term Assets too high?
Daito Pharmaceutical Co's current Total Long-Term Assets is 円36,654 Mil. Overall, Daito Pharmaceutical Co has a GF Score™ of 83/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Daito Pharmaceutical Co's Total Long-Term Assets compare to ZTS?
Daito Pharmaceutical Co's Total Long-Term Assets of 円36,654 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Long-Term Assets for a Drug Manufacturers company?
A good Total Long-Term Assets depends on the Drug Manufacturers industry context. However, Total Long-Term Assets should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Long-Term Assets mean?
A high Total Long-Term Assets can signal that a stock is expensive relative to its fundamentals. Total Long-Term Assets are assets that are expected to be realized in cash, sold or consumed longer than one year. View historical data on Daito Pharmaceutical Co and its competitors. Daito Pharmaceutical Co's current Total Long-Term Assets is 円36,654 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Daito Pharmaceutical Co stock overvalued right now?
Based on GuruFocus' analysis, Daito Pharmaceutical Co (TSE:4577) is currently considered Fairly Valued. The stock's GF Value™ is 円1,280.49, compared to a current price of 円1,276.00 — trading 0.4% below its estimated fair value. The current Total Long-Term Assets is 円36,654 Mil. Daito Pharmaceutical Co's overall GF Score™ is 83/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Long-Term Assets calculated?
Total Long-Term Assets is calculated from a company's financial statements. For Daito Pharmaceutical Co (TSE:4577), the current Total Long-Term Assets is 円36,654 Mil as of Feb. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Daito Pharmaceutical Co (TSE:4577) Overvalued in 2026?

Based on GuruFocus' analysis, Daito Pharmaceutical Co stock appears to be undervalued. The current stock price of 円1,276.00 is trading 0.4% below its estimated GF Value™ of 円1,280.49. GuruFocus considers Daito Pharmaceutical Co to be Fairly Valued.

Key valuation signals for TSE:4577:

  • Total Long-Term Assets: 円36,654 Mil
  • GF Value™: 円1,280.49 vs. price of 円1,276.00 (0.4% below fair value)
  • GF Score™: 83/100 with 3 warning signs

No single metric tells the full story. See the TSE:4577 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Daito Pharmaceutical Co Business Description

Address 326 Yokamachi, Toyama, JPN, 939-8567
Daito Pharmaceutical Co Ltd is engaged in the research and development of pharmaceutical products. The company also undertakes contract manufacturing.
83GF Score

Get the complete analysis for TSE:4577

Total Long-Term Assets is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円1,276.00
Price
円1,280.49
GF Value